FDA approves Eli Lilly's once-weekly insulin pen, setting up rivalry with Novo
Eli Lilly’s once-weekly basal insulin shot Onswik has been approved by the FDA for patients with type 2 diabetes. Lilly has touted Onswik as a longer-acting alternative to daily basal insulin injections. It will compete ...
September 24, 2026 12:16 PM EDT PharmaFDA+ FDA approves Eli Lilly's once-weekly insulin pen, setting up rivalry with Novo Nicole DeFeudis Senior Reporter Eli Lilly’s once-weekly basal insulin shot Onswik has been approved by the FDA for patients with type 2 diabetes. Lilly has touted Onswik as a … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that